1. Home
  2. NOTV vs MDAI Comparison

NOTV vs MDAI Comparison

Compare NOTV & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • MDAI
  • Stock Information
  • Founded
  • NOTV 1974
  • MDAI 2013
  • Country
  • NOTV United States
  • MDAI United States
  • Employees
  • NOTV N/A
  • MDAI N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • MDAI Medical/Dental Instruments
  • Sector
  • NOTV Health Care
  • MDAI Health Care
  • Exchange
  • NOTV Nasdaq
  • MDAI Nasdaq
  • Market Cap
  • NOTV 57.7M
  • MDAI 51.9M
  • IPO Year
  • NOTV 1997
  • MDAI N/A
  • Fundamental
  • Price
  • NOTV $1.37
  • MDAI $1.99
  • Analyst Decision
  • NOTV Strong Buy
  • MDAI Strong Buy
  • Analyst Count
  • NOTV 1
  • MDAI 1
  • Target Price
  • NOTV $5.00
  • MDAI $3.50
  • AVG Volume (30 Days)
  • NOTV 394.8K
  • MDAI 275.7K
  • Earning Date
  • NOTV 08-06-2025
  • MDAI 11-05-2025
  • Dividend Yield
  • NOTV N/A
  • MDAI N/A
  • EPS Growth
  • NOTV N/A
  • MDAI N/A
  • EPS
  • NOTV N/A
  • MDAI N/A
  • Revenue
  • NOTV $505,299,000.00
  • MDAI $27,549,000.00
  • Revenue This Year
  • NOTV $5.64
  • MDAI N/A
  • Revenue Next Year
  • NOTV $5.16
  • MDAI $60.05
  • P/E Ratio
  • NOTV N/A
  • MDAI N/A
  • Revenue Growth
  • NOTV 0.85
  • MDAI 22.27
  • 52 Week Low
  • NOTV $1.15
  • MDAI $0.82
  • 52 Week High
  • NOTV $6.48
  • MDAI $3.25
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 32.94
  • MDAI 46.01
  • Support Level
  • NOTV $1.36
  • MDAI $1.78
  • Resistance Level
  • NOTV $1.68
  • MDAI $2.02
  • Average True Range (ATR)
  • NOTV 0.11
  • MDAI 0.11
  • MACD
  • NOTV -0.02
  • MDAI 0.02
  • Stochastic Oscillator
  • NOTV 4.00
  • MDAI 58.33

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: